Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation-Reference-Cited by-同舟云学术

Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation

Published:2015-07 Issue:4 Volume:34 Page:305-309
ISSN:0254-8860
Container-title:Indian Journal of Gastroenterology
language:en
Short-container-title:Indian J Gastroenterol

Author:

Saigal Sanjiv,Choudhary Narendra S.,Saraf Neeraj,Gautam Dheeraj,Lipi Lipika,Rastogi Amit,Goja Sanjay,Menon P. Balachandran,Bhangui Prashant,Ramachandra Sumana K.,Soin Arvinder S.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s12664-015-0578-z.pdf

Reference29 articles.

1. Feray C, Samuel D, Thiers V, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest. 1992;89:1361–5.

2. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992;103:317–22.

3. Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl. 2002;10 Suppl 1:S14–8.

4. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334:815–20.

5. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol. 2000;32:673–84.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

2. Long-term Management of the Adult Liver Transplantation Recipients;Journal of Clinical and Experimental Hepatology;2021-03

3. Outcome of hepatitis C–related liver transplantation in direct-acting antiviral era;Indian Journal of Gastroenterology;2020-11-24

4. Efficacy And Safety of Sofosbuvir Based Regimens For Treatment of Hepatitis C Recurrence After Living Donor Liver Transplantation: An Experience From India;Journal of Clinical and Experimental Hepatology;2018-06

5. Pre-emptive Treatment of HCV after Living Donor Liver Transplantation with Direct-Acting Antiviral Agents;Journal of Gastrointestinal Surgery;2018-04-20